Lupin receives Great Place To Work certification across global operations
Recognition based on study covering subsidiaries and employee participation
Author
CuraTeQ Biologics reports Phase 3 results for BP11 biosimilar to Xolair
Study meets primary endpoints in chronic spontaneous urticaria across Europe and India
Bayer revises access model for Eylea 2mg in India to expand patient eligibility
Company aims to lower upfront cost to support early treatment initiation for retinal diseases
Patent expiries ahead, is India Pharma Inc ready?
Beyond the semaglutide momentum, a larger wave of patent expiries is set to unfold between 2026 and 2032. For Indian pharma, the…
Emcure Pharmaceuticals revises price of Poviztra semaglutide injection in India
Weight management drug to be available from Rs 3,999 per month from April 3, 2026
Lupin completes acquisition of VISUfarma
The integration of VISUfarma has expanded Lupin’s ophthalmology portfolio to over 60 branded products spanning dry eye, glaucoma,…
Glenmark to manage end-to-end commercialisation and distribution for RYALTRIS in US
RYALTRIS is Glenmark’s first innovative product introduced into the US market
Agilent expands India’s scientific ecosystem with new customer experience centre in Mumbai
Agilent Technologies has announced the opening of its Customer Experience Center (CEC) and office in Mumbai, reinforcing its…
Express Pharma April 2026
India's Foremost Pharma & Biotech Magazine ~ Patent Expiries Ahead: Is India Pharma Inc Ready?
Enthral.ai partners with Alembic Pharmaceuticals to deploy LMS platform
Platform to support compliance, training and documentation for over 9,000 learners